Navigation Links
Nanotubes could help study retrovirus transmission between human cells
Date:6/26/2008

radii.

But researchers had difficulties, says Sasaki, perhaps because they used a composite lipid called egg PC that requires unnecessarily high energies to bend into a tubular shape.

Egg PC is inexpensive, readily available, and offers good, stable membrane properties. It is the usual lipid of choice in forming nanocylinders via mechanical stretching techniques.

But Sandia postdoctoral researcher Haiqing Lui instead used POPC a single pure lipid requiring half the bending energy of egg PC.

She was trying to generate nanotubes by a completely different approach that involved the use of motor proteins to stretch naturally occurring membranes into tubes.

Working with Sandia researcher George Bachand, she serendipitously found that interaction of the POPC membrane with a high affinity protein called streptavidin alone was enough to form the nanotubes.

"Perhaps this information linking membrane bending energy with nanotube formation may provide some clue about the membrane structure and the cell's ability to form such intercellular connections," Sasaki says.

The formation was confirmed by Sandia researcher Carl Hayden, who characterized the nanotube formation through a confocal imaging microscope. The custom instrument allows pixel-by-pixel examination of the protein interaction with the membranes comprising the nanotubes by detecting the spectrum and lifetimes of fluorescent labels on the proteins.

Nanotube formation had been noticed previously by cell biologists, but they had dismissed the tiny outgrowths as "junk an aberration of cells growing in culture," says Sasaki. "The reason they were only noticed recently as trafficking routes is because of labeling studies that marked organelles and proteins. This allowed a focused look at what these nanostructures might be used for."

It became clear, says Sasaki, that the organelles were being transported with "specific directionality" on t
'/>"/>

Contact: Neal Singer
nsinger@sandia.gov
505-845-7078
DOE/Sandia National Laboratories
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Livermore researchers use carbon nanotubes for molecular transport
2. Spin control: New technique sorts nanotubes by length
3. Using carbon nanotubes to seek and destroy anthrax toxin and other harmful proteins
4. Another type of nanotube, a how-to guide to making bamboo-structured carbon nanotubes
5. Using nanotubes to detect and repair cracks in aircraft wings, other structures
6. Climate change could severely impact Californias unique native plants
7. Newly identified role for power plants in human cells could lead to targeted therapies
8. Certain anticancer agents could be harmful to patients with heart disease
9. Laser fluorescence could find life on Mars
10. A novel X-ray source could be brightest in the world
11. Test of bacteria toxin delivery system could pave way for new antibiotic drugs
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/14/2015)... May 14, 2015 Research and Markets ... "Fingerprint Sensors Market in Smart Mobile Devices " ... believes that 2014 was a watershed year for fingerprint ... of ,Apple Pay,. Apple gave fingerprint sensors a raison ... service. Fingerprint sensors are a must-have feature in flagship ...
(Date:5/11/2015)... Calif. , May 11, 2015  Synaptics ... of human interface solutions, today announced the appointment ... President and Chief Financial Officer, reporting to ... replaces Synaptics, current Chief Financial Officer, Kathleen ... 2014. Mr. Ali brings extensive ...
(Date:5/11/2015)... N.Y. , May 11, 2015 Curemark ... announced the start of a new Phase III double ... of its novel formulation, CM-AT, on all children ages ... of its FDA Phase III double blinded clinical trial ... had low levels of the digestive enzyme chymotrypsin. This ...
Breaking Biology News(10 mins):Global Smart Mobile Devices Fingerprint Sensors Market 2015-2019: Key Vendors are Authentec, Validity Sensors, Fingerprint Cards, Next Biometrics Group. IDEX, and Qualcomm 2Synaptics Appoints Wajid Ali as Senior Vice President and Chief Financial Officer 2Curemark, LLC, Launches New Phase III Trial in Expanded Population of Children with Autism 2
... of an unknown perpetrator who has committed a crime will ... MC scientists, in collaboration with their Polish colleagues, have discovered ... color. Their findings will be published today in the Springer ... that on the basis of DNA information it is possible ...
... (PHILADELPHIA) An international team of researchers led ... Penn Medicine,s Institute for Translational Medicine and Therapeutics, ... Paris-based Fondation Leducq to study the molecular genetics ... Mechanisms of Novel Genes Associated with Plasma Lipids ...
... Many young people who,ve just learned that they have cancer ... lives could rob them of their ability ever to have ... population: Of the 1.5 million people diagnosed with cancer in ... The good news, according to an article in ...
Cached Biology News:Hair color of unknown offenders is no longer a secret 2Penn Medicine researcher receives $6 million grant for cardiovascular disease study 2Advancements in fertility preservation provide oncology patients new options 2Advancements in fertility preservation provide oncology patients new options 3
(Date:6/1/2015)... June 1, 2015  Fennec Pharmaceuticals, Inc. (TSX: ... interim results from a poster presented today entitled, ... randomised phase III trial of the efficacy of ... receiving cisplatin (Cis) monotherapy for standard risk hepatoblastoma ... Society of Clinical Oncology (ASCO) 2015 Annual Meeting ...
(Date:6/1/2015)... , ROCHESTER, Minn. and ... 2015 Baxter Ventures, the venture arm of ... Clinic and Velocity Pharmaceutical Development, LLC ("VPD") today announced ... a unique collaboration model initiated by Baxter Ventures to ... in the areas of immunology, hematology, and oncology. Following ...
(Date:6/1/2015)... Esperance Pharmaceuticals Inc. today reported positive results ... in ovarian cancer patients resistant to paclitaxel. EP-100 is ... cancer cells that overexpress luteinizing hormone-releasing hormone (LHRH) receptors ... wide range of cancers. Results of ... were presented at the 2015 ASCO Annual Meeting ...
(Date:6/1/2015)... 2015 Research and Markets ( ... the "2015 Strategies in European Immunoprotein ... offering. This new 273-page report ... market, including emerging tests, technologies, instrumentation, sales ... leading suppliers. Companies Mentioned: ...
Breaking Biology Technology:Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 2Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 3Fennec Announces Presentation Of Positive Interim Sodium Thiosulfate Phase III Safety Data At The 2015 ASCO Annual Meeting 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 2Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 3Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 4Baxter Ventures, Mayo Clinic And Velocity Pharmaceutical Development Announce The Formation Of Vitesse Biologics, LLC, A Company Structured To Accelerate Therapeutic Innovation 5Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 2Esperance Reports Positive EP-100 Phase ll Results in Ovarian Cancer at 2015 ASCO Annual Meeting 3
... - CEO Michael V. Novinski to Discuss Plans ... CEDAR KNOLLS, N.J., Jan. 31 Emisphere,Technologies, Inc. ... will host a,teleconference on Thursday, February 7, at ... V. Novinski will discuss the company,s,emerging business strategy. ...
... Names Board of Directors, SAN DIEGO, Jan. ... developing therapeutics for the,treatment of Alzheimer,s disease, announced ... Series A round of financing. The financing was ... Alta Partners. Additional,investors included AgeChem Venture Fund, and ...
... Foundation Continues Research Initiatives in Search of a Cure and Therapies ... ... N.J., Jan. 31 The Christopher and Dana,Reeve Foundation (CDRF), which ... improving the quality of life for people,living with paralysis through grants, ...
Cached Biology Technology:Emisphere to Host Business Strategy Conference Call on February 7 2Emisphere to Host Business Strategy Conference Call on February 7 3Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments 2Sonexa Therapeutics, Inc., Raises $30 Million in Series A Financing to Focus on Alzheimer's Treatments 3Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 2Christopher and Dana Reeve Foundation Awards Nearly $2 Million in Individual Research Grants 3
... Science LAS-3000 imaging system combines new ... user interface, providing significantly improved system ... modularities. The system is especially dedicated ... standard system for Western blotting applications.,Fuiji's ...
This pump accomodates StemSep ; pump feed columns of the following sizes : 0.3in., 0.5in., 0.6in., and 1.0in.....
... m7G Capping system features the ... of the components needed to ... the end of di- or ... feature high efficiency capping (virtually ...
... Removal , , Removes ... cross-reactivity with other proteins , Simple, just ... Economical new surface technology, not based on ... with protein analysis. SurfactAway offers a simple ...
Biology Products: